Apollon Formularies annual loss narrows as revenue jumps
Apollon Formularies PLC – London-based medical cannabis pharmaceutical firm – Reports revenue in 2022 rose 45% to GBP286,144 from GBP197,671 the year prior. Pretax loss narrowed to GBP704,891 from GB…